Sonelokimab, lutikizumab, and adalimumab showed the highest HiSCR-50 response rates in moderate to severe hidradenitis suppurativa, per a network meta-analysis in JAMA Dermatology. In a network meta-analysis of approved and pipeline medications for...
TUESDAY, July 15, 2025 (HealthDay News) -- Atopic dermatitis (AD) was associated with an increased risk for chronic kidney disease (CKD) in an Asian population, according to a study published online July 10 in the Journal of Dermatology.Hsi-Chih Chen, from the...
TUESDAY, July 15, 2025 (HealthDay News) -- A high dietary inflammatory index (DII), which quantifies the inflammatory potential of diet, is associated with increased prevalence of atopic dermatitis (AD), according to a study published online June 19 in Frontiers of...
Sonelokimab, lutikizumab, and adalimumab showed the highest HiSCR-50 response rates in moderate to severe HS, per a network meta-analysis in JAMA Dermatology.
MONDAY, July 14, 2025 (HealthDay News) -- Patients with higher-severity alopecia areata (AA) have a higher prevalence and incidence of comorbid atopic dermatitis (AD), according to a study published online June 26 in the Journal of Investigative...
TUESDAY, July 15, 2025 (HealthDay News) -- Atopic dermatitis (AD) was associated with an increased risk for chronic kidney disease (CKD) in an Asian population, according to a study published online July 10 in the Journal of Dermatology.Hsi-Chih Chen, from the...
TUESDAY, July 15, 2025 (HealthDay News) -- A high dietary inflammatory index (DII), which quantifies the inflammatory potential of diet, is associated with increased prevalence of atopic dermatitis (AD), according to a study published online June 19 in Frontiers of...
Sonelokimab, lutikizumab, and adalimumab showed the highest HiSCR-50 response rates in moderate to severe HS, per a network meta-analysis in JAMA Dermatology.
MONDAY, July 14, 2025 (HealthDay News) -- Patients with higher-severity alopecia areata (AA) have a higher prevalence and incidence of comorbid atopic dermatitis (AD), according to a study published online June 26 in the Journal of Investigative...
Dr. David Epstein advocates for reframing failure as a springboard for adaptation, innovation, and long-term success, rather than a discouraging setback.
Dr. Linda Girgis explains the importance of DEI initiatives in the medical sector and offers physicians strategies for advancing DEI in their own practices.
Dr. Mark Sullivan discusses strategies for restoring the patient-physician relationship in response to the ongoing erosion of public trust in healthcare.
This course discusses a study that examined the prognostic role of tumor budding in cutaneous squamous cell carcinoma.
This course discusses a literature review that provided updates and challenges related to AI and dermatological care for patients with skin of color.
This course discusses a review that provides guidance for cardiovascular disease screening type and frequency in patients with psoriasis.
Discharge plan: prescribe one medical cartoon daily for ongoing grin...
Take a break for a little medicinal laughter with this week's medical...
Viewing this medical cartoon may enhance emotional vital signs, manifested by a smile or...
Strong collaboration between physicians and SUD treatment programs provides continuity of care, an essential factor in SUD treatment outcomes.
Claims denials increased by 60% in 2024, underscoring the urgent need for more accurate first-pass submissions through enhanced data and EHR utilization.
Nine states—and a dozen more soon—now allow internationally trained physicians to bypass full US residencies, seeking to mitigate rural physician shortages.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
